Treatment of murine disseminated candidiasis with L-743,872

被引:60
作者
Graybill, JR [1 ]
Najvar, LK [1 ]
Luther, MF [1 ]
Fothergill, AW [1 ]
机构
[1] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX
关键词
D O I
10.1128/AAC.41.8.1775
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
L-743,872 (M991), which is a pneumocandin derivative, was evaluated in a mouse model of disseminated candidiasis caused by a fluconazole-resistant isolate of Candida albicans, In immunocompetent mice M991 prolonged survival at doses as low as 0.0125 mg/kg of body weight per day. In neutropenic mice 0.05 mg/kg was the lowest effective dose. M991 is a very potent drug for treatment of disseminated candidiasis.
引用
收藏
页码:1775 / 1777
页数:3
相关论文
共 21 条
  • [1] THE LIPOPEPTIDE ANTIMYCOTIC, CILOFUNGIN MODULATES THE INCORPORATION OF GLUCAN-ASSOCIATED PROTEINS INTO THE CELL-WALL OF CANDIDA-ALBICANS
    ANGIOLELLA, L
    SIMONETTI, N
    CASSONE, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (06) : 1137 - 1146
  • [2] IN-VITRO EVALUATION OF THE PNEUMOCANDIN ANTIFUNGAL AGENT L-733560, A NEW WATER-SOLUBLE HYBRID OF L-705589 AND L-731373
    BARTIZAL, K
    SCOTT, T
    ABRUZZO, GK
    GILL, CJ
    PACHOLOK, C
    LYNCH, L
    KROPP, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) : 1070 - 1076
  • [3] INVITRO ANTIFUNGAL ACTIVITIES AND INVIVO EFFICACIES OF 1,3-BETA-D-GLUCAN SYNTHESIS INHIBITORS L-671,329, L-646,991, TETRAHYDROECHINOCANDIN-B, AND L-687,781, A PAPULACANDIN
    BARTIZAL, K
    ABRUZZO, G
    TRAINOR, C
    KRUPA, D
    NOLLSTADT, K
    SCHMATZ, D
    SCHWARTZ, R
    HAMMOND, M
    BALKOVEC, J
    VANMIDDLESWORTH, F
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) : 1648 - 1657
  • [4] COMPARISON OF INVIVO ACTIVITY OF FLUCONAZOLE WITH THAT OF AMPHOTERICIN-B AGAINST CANDIDA-TROPICALIS, CANDIDA-GLABRATA, AND CANDIDA-KRUSEI
    FISHER, MA
    SHEN, SH
    HADDAD, J
    TARRY, WF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) : 1443 - 1446
  • [5] FLUCONAZOLE TREATMENT OF CANDIDA-ALBICANS INFECTION IN MICE - DOES IN-VITRO SUSCEPTIBILITY PREDICT IN-VIVO RESPONSE
    GRAYBILL, JR
    NAJVAR, LK
    HOLMBERG, JD
    CORREA, A
    LUTHER, MF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) : 2197 - 2200
  • [6] CILOFUNGIN (LY121019), AN ANTIFUNGAL AGENT WITH SPECIFIC ACTIVITY AGAINST CANDIDA-ALBICANS AND CANDIDA-TROPICALIS
    HALL, GS
    MYLES, C
    PRATT, KJ
    WASHINGTON, JA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (09) : 1331 - 1335
  • [7] FLUCONAZOLE-RESISTANT CANDIDA IN AIDS PATIENTS
    HEINIC, GS
    STEVENS, DA
    GREENSPAN, D
    MACPHAIL, LA
    DODD, CL
    STRINGARI, S
    STRULL, WM
    HOLLANDER, H
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1993, 76 (06): : 711 - 715
  • [8] INCREASED ANTIFUNGAL ACTIVITY OF L-733,560, A WATER-SOLUBLE, SEMISYNTHETIC PNEUMOCANDIN, IS DUE TO ENHANCED INHIBITION OF CELL-WALL SYNTHESIS
    KURTZ, MB
    DOUGLAS, C
    MARRINAN, J
    NOLLSTADT, K
    ONISHI, J
    DREIKORN, S
    MILLIGAN, J
    MANDALA, S
    THOMPSON, J
    BALKOVEC, JM
    BOUFFARD, FA
    DROPINSKI, JF
    HAMMOND, ML
    ZAMBIAS, RA
    ABRUZZO, G
    BARTIZAL, K
    MCMANUS, OB
    GARCIA, ML
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) : 2750 - 2757
  • [9] MORPHOLOGICAL EFFECTS OF LIPOPEPTIDES AGAINST ASPERGILLUS-FUMIGATUS CORRELATE WITH ACTIVITIES AGAINST (1,3)-BETA-D-GLUCAN SYNTHASE
    KURTZ, MB
    HEATH, IB
    MARRINAN, J
    DREIKORN, S
    ONISHI, J
    DOUGLAS, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) : 1480 - 1489
  • [10] CILOFUNGIN (LY121019) SHOWS NONLINEAR PLASMA PHARMACOKINETICS AND TISSUE PENETRATION IN RABBITS
    LEE, JW
    KELLY, P
    LECCIONES, J
    COLEMAN, D
    GORDEE, R
    PIZZO, PA
    WALSH, TJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) : 2240 - 2245